Sarah C. Hull

Sarah C. Hull, MD, MBE is an Associate Professor of Medicine (Cardiology) at Yale School of Medicine, where she serves as Associate Director of the Program for Biomedical Ethics and Cardiology Course Director. She is affiliated with the Department of Internal Medicine, Cardio-Oncology Program, Cardiovascular Imaging Program, and Yale Cancer Center.

Education:

• AB, Biochemical Sciences, Harvard University (2003)
• MD, University of Pennsylvania School of Medicine (2008)
• MBE, University of Pennsylvania School of Medicine (2008)
• Residency, Hospital of the University of Pennsylvania (2011)
• Fellowship, Yale University School of Medicine (2014)

Her research and scholarly work focus on bioethics in cardiology and public health, with key interests in end-of-life care, LVAD deactivation, shared decision-making in cardio-oncology, nutrition ethics, vaccine ethics, and reproductive health ethics. She advocates for integrating ethical frameworks into clinical cardiology practice and medical education. Her work often addresses moral uncertainty, physician-patient communication, and systemic inequities in healthcare access.

Recent publications highlight trends in cardioethics, exploring AI's role in moral agency, ethical boundaries in medicine, and curriculum development for ethics training in cardiology. She also contributes to cardio-oncology research, particularly in predicting cardiovascular outcomes in cancer survivors using advanced imaging.

Scientific Awards:

• Bohmfalk Prize for Teaching in Basic Sciences (2021)

Sarah C. Hull is actively involved in medical education and ethics leadership. She advises on clinical ethics policy and collaborates with interdisciplinary teams across Yale. She has no listed advisees or grants in the provided text, but her role as Associate Director suggests mentorship and program leadership. She is part of research teams in cardio-oncology and ethics, contributing to collaborative publications.

Labs and Teams: She collaborates with researchers in the Cardio-Oncology Program and the Program for Biomedical Ethics, and is a frequent co-author with experts in cardiology, neurology, and oncology at Yale.